LAVA Therapeutics NV (LAVA Therapeutics NV) Market Cap : $60.21 Mil (As of Jun. 09, 2024)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). LAVA Therapeutics NV's share price for the quarter that ended in Mar. 2024 was $3.33. LAVA Therapeutics NV's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 26.29 Mil. Therefore, LAVA Therapeutics NV's market cap for the quarter that ended in Mar. 2024 was $87.55 Mil.

LAVA Therapeutics NV's quarterly market cap increased from Sep. 2023 ($38.64 Mil) to Dec. 2023 ($41.54 Mil) and increased from Dec. 2023 ($41.54 Mil) to Mar. 2024 ($87.55 Mil).

LAVA Therapeutics NV's annual market cap declined from Dec. 2021 ($141.77 Mil) to Dec. 2022 ($92.01 Mil) and declined from Dec. 2022 ($92.01 Mil) to Dec. 2023 ($41.54 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. LAVA Therapeutics NV's Enterprise Value for Today is $-28.23 Mil.

LAVA Therapeutics NV Market Cap Historical Data

The historical data trend for LAVA Therapeutics NV's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Market Cap Chart

LAVA Therapeutics NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

141.77

92.01

41.54

LAVA Therapeutics NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial													43.64	53.37	38.64	41.54	87.55

Competitive Comparison of LAVA Therapeutics NV's Market Cap

For the Biotechnology subindustry, LAVA Therapeutics NV's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LAVA Therapeutics NV's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LAVA Therapeutics NV's Market Cap distribution charts can be found below:

* The bar in red indicates where LAVA Therapeutics NV's Market Cap falls into.

LAVA Therapeutics NV Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

LAVA Therapeutics NV's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$1.58	*	26.2891
	=	$41.54

LAVA Therapeutics NV's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	$3.33	*	26.2922
	=	$87.55

LAVA Therapeutics NV (NAS:LVTX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

LAVA Therapeutics NV Market Cap Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

4PKB:Germany

Address

Yalelaan 62, Utrecht, UT, NLD, 3584 CM

Website

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.